Lantern Pharma Inc. ( LTRN) - Key Metrics
LTRN Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.57 | -$0.24 | -$0.24 |
| 2026Q1 | $0 | -$0.30 | -$0.34 | -$0.34 |
| 2025Q4 | $0 | -$0.37 | -$0.26 | -$0.26 |
| 2025Q3 | $0 | -$0.39 | -$0.42 | -$0.42 |
| 2025Q2 | $0 | -$0.40 | -$0.37 | -$0.37 |
LTRN Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -1.83 |
| 2026Q1 | 0% | -1.14 |
| 2025Q4 | 0% | -2.10 |
| 2025Q3 | 0% | -2.79 |
| 2025Q2 | 0% | -1.98 |
LTRN
Price: $2.52
52 week price:
Earnings Per Share: -1.45 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 2116
Market Capitalization: 33.9 million